CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,181,169 | -77.3% | 146,289 | -83.3% | 0.01% | -75.0% |
| Q2 2023 | $9,590,974 | -22.5% | 875,888 | -38.3% | 0.02% | -31.4% |
| Q1 2023 | $12,378,389 | +407.4% | 1,419,540 | +264.8% | 0.04% | +337.5% |
| Q4 2022 | $2,439,638 | +132.6% | 389,097 | +29.8% | 0.01% | +100.0% |
| Q3 2022 | $1,049,000 | +215.0% | 299,747 | +165.5% | 0.00% | +300.0% |
| Q2 2022 | $333,000 | +25.2% | 112,910 | +32.2% | 0.00% | 0.0% |
| Q1 2022 | $266,000 | +180.0% | 85,414 | +204.0% | 0.00% | – |
| Q4 2021 | $95,000 | -92.0% | 28,100 | -89.6% | 0.00% | -100.0% |
| Q2 2021 | $1,183,000 | -74.6% | 271,216 | -73.6% | 0.00% | -75.0% |
| Q1 2021 | $4,664,000 | -27.2% | 1,027,236 | -7.9% | 0.01% | -33.3% |
| Q4 2020 | $6,403,000 | +261.1% | 1,115,477 | +355.5% | 0.02% | +200.0% |
| Q3 2020 | $1,773,000 | +64.8% | 244,893 | -20.6% | 0.01% | +20.0% |
| Q2 2020 | $1,076,000 | +125.6% | 308,269 | -4.3% | 0.01% | +25.0% |
| Q1 2020 | $477,000 | -37.3% | 322,063 | -17.1% | 0.00% | +100.0% |
| Q4 2019 | $761,000 | +417.7% | 388,308 | +1253.0% | 0.00% | – |
| Q3 2019 | $147,000 | – | 28,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |